Models to Study Atherosclerosis: A Mechanistic Insight

By  

Current Vascular Pharmacology, Vol. 7, Iss. 1, 2009-01 ,pp. : 75-109

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis

By Karadag-Saygi Evrim   Akyuz Gulseren   Bizargity Peyman   Ay Pinar  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 1033-1036

Informa Healthcare

Access to resources Recommend Favorite

Osteoprotegerin is not associated with angiographic coronary calcification

By Gogo Prospero   Schneider David   Terrien Edward   Sobel Burton   Dauerman Harold  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 3, 2006-12 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite

Osteoprotegerin as a marker of atherosclerosis: A systematic update

By Hosbond Susanne Elisabeth   Poulsen Tina Svenstrup   Diederichsen Axel Cosmus Pyndt   Nybo Mads   Rasmussen Lars Melholt   Mickley Hans  

Scandinavian Cardiovascular Journal, Vol. 46, Iss. 4, 2012-08 ,pp. : 203-211

Informa Healthcare

Access to resources Recommend Favorite

Effect of olmesartan on oxidative stress in hypertensive patients. Mechanistic support to clinical trials derived evidence

By Calò Lorenzo A.   Maso Lucia Dal   Caielli Paola   Pagnin Elisa   Fusaro Maria   Davis Paul A.   Pessina Achille C.  

Blood Pressure, Vol. 20, Iss. 6, 2011-12 ,pp. : 376-382

Informa Healthcare

Access to resources Recommend Favorite